Sign In

Christie Medical Holdings to Display VeinViewer Technology at AVA Annual Scientific Meeting

Publication Date: 9/25/2015

AVA/Dallas – (September 25, 2015) – Christie® Medical Holdings, Inc., the global leader in vein finding technology, will exhibit its VeinViewer® Vision2 and VeinViewer® Flex at the Association for Vascular Access (AVA) annual scientific meeting, September 26-29 at the Gaylord Texan Resort and Convention Center in booth 100. The meeting is the premier event dedicated to scientific research and clinical best practices in vascular access.

VeinViewer is a vascular access imaging device that can help the clinician find the optimal venipuncture site for first stick success in placing an IV catheter and avoid potential complications. With HD imaging and exclusive Df2 (digital full field) technology, VeinViewer is the only vein illuminator that provides benefits for all patients during the entire vascular access procedure and allows clinicians to employ a hands-free, Eyes On Patient (EOP) technique. Clinicians can assess the venous pattern of any patient regardless of age, skin tone, edema or obesity and VeinViewer can be used to help assess the patient pre-, during- and post-access.

“VeinViewer allows healthcare professionals to make a more informed decision when locating veins,” says George Pinho, president, Christie Medical Holdings, Inc. “The most obvious vein is not always the best choice, and VeinViewer can help guide clinicians to a vein that is best for the patient.”

VeinViewer uses near-infrared light, and exclusive technology such as Active Vascular Imaging Navigation (AVIN) to create a digital image of patient vasculature in real time. VeinViewer allows clinicians to see peripheral veins up to 10mm deep and blood patterns up to 15mm deep, and can locate valves and bifurcations, which aids in decision making for the point of insertion. In post-assessment procedures, clinicians can assess the patency of the vessel to help avoid complications.

To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex, please visit

About Christie Medical Holdings, Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit

Follow us on Twitter @christiemed

Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.